CA1303500C - Vaccin contre la peritonite infectieuse chez les chats - Google Patents

Vaccin contre la peritonite infectieuse chez les chats

Info

Publication number
CA1303500C
CA1303500C CA 529116 CA529116A CA1303500C CA 1303500 C CA1303500 C CA 1303500C CA 529116 CA529116 CA 529116 CA 529116 A CA529116 A CA 529116A CA 1303500 C CA1303500 C CA 1303500C
Authority
CA
Canada
Prior art keywords
virus
fipv
temperature
passage
feline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA 529116
Other languages
English (en)
Inventor
Charles A. Baldwin
Fredric W. Scott
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cornell Research Foundation Inc
Merck Sharp and Dohme LLC
Original Assignee
Cornell Research Foundation Inc
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cornell Research Foundation Inc, Schering Corp filed Critical Cornell Research Foundation Inc
Application granted granted Critical
Publication of CA1303500C publication Critical patent/CA1303500C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CA 529116 1986-02-06 1987-02-05 Vaccin contre la peritonite infectieuse chez les chats Expired - Lifetime CA1303500C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82663886A 1986-02-06 1986-02-06
US826,638 1986-02-06

Publications (1)

Publication Number Publication Date
CA1303500C true CA1303500C (fr) 1992-06-16

Family

ID=25247142

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 529116 Expired - Lifetime CA1303500C (fr) 1986-02-06 1987-02-05 Vaccin contre la peritonite infectieuse chez les chats

Country Status (5)

Country Link
EP (1) EP0261168A1 (fr)
JP (1) JPS63502828A (fr)
AU (1) AU604682B2 (fr)
CA (1) CA1303500C (fr)
WO (1) WO1987004624A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5667785A (en) * 1987-10-01 1997-09-16 Pfizer Inc. Vaccine for protection of cats against feline infectious peritonitis
IL87911A0 (en) * 1987-10-01 1989-03-31 Norden Lab Inc Vaccine for protection of cats against feline infectious peritonitis
CA2005291C (fr) * 1988-12-30 1999-01-26 Beverly Dale Instruments de diagnostic du virus de la peritonite infectieuse des felins
NZ240558A (en) 1990-11-14 1994-11-25 Smithkline Beecham Corp Recombinant feline coronavirus s proteins useful in diagnosis and vaccination against feline peritonitis virus disease
AU5530498A (en) * 1996-12-18 1998-07-15 Synbiotics Corporation A specific diagnostic for antibodies to feline infectious peritonitis virus
US6106841A (en) * 1998-02-04 2000-08-22 Heska Corporation Delivery method for recombinant raccoon poxvirus
CN116042538B (zh) * 2022-11-24 2024-05-07 华中农业大学 一株猫冠状病毒及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4021302A (en) * 1966-02-18 1977-05-03 Burroughs Wellcome & Co., Inc. Cell cultures
US4195130A (en) * 1978-04-20 1980-03-25 Cornell Research Foundation, Inc. Propagation of feline infectious peritonitis virus in tissue cultures
JPS5576820A (en) * 1978-11-30 1980-06-10 Wellcome Found Feline infectious peritonitis vaccine
AU5329279A (en) * 1978-11-30 1980-06-05 Wellcome Foundation Limited, The Feline infectious peritonitis vaccine
US4303644A (en) * 1979-10-16 1981-12-01 Norden Laboratories, Inc. Feline infectious peritonitis virus vaccines

Also Published As

Publication number Publication date
EP0261168A1 (fr) 1988-03-30
WO1987004624A1 (fr) 1987-08-13
AU604682B2 (en) 1991-01-03
JPS63502828A (ja) 1988-10-20
AU7037287A (en) 1987-08-25

Similar Documents

Publication Publication Date Title
Snyder et al. Group and strain-specific neutralization sites of infectious bursal disease virus defined with monoclonal antibodies
Prinzie et al. Experimental live attenuated rubella virus vaccine: clinical evaluation of Cendehill strain
CA1045546A (fr) Vaccin a cytomegalovirus fortement attenue
US3937812A (en) Feline calicivirus vaccine and production thereof
US3944469A (en) Feline calicivirus vaccine and production thereof
JPS6257307B2 (fr)
Wu et al. Antigenic and immunogenic characterization of infectious bronchitis virus strains isolated in China between 1986 and 1995
AU604682B2 (en) Feline infectious peritonitis vaccine
US5460815A (en) Feline infectious peritonitis vaccine and method of preparation
US7029682B2 (en) Inactivated vaccine against feline calicivirosis
US5972350A (en) Feline vaccines containing Chlamydia psittaci and method for making the same
EP0310362B1 (fr) Vaccin pour la protection des chats contre la péritonite infectieuse féline
US5043157A (en) Feline infectious peritonitis vaccine and method of preparation
CA1058074A (fr) Vaccin contre la rhinotracheite des felins et mode de production
CA2378802C (fr) Vaccin inactive contre la calicivirose feline
US4287178A (en) Feline rhinotracheitis vaccine and production and use thereof
US5670156A (en) Feline infectious peritonitis vaccine and method of preparation
ZA200402352B (en) Chicken anemia virus vaccine from cell line.
Bayyari et al. Antigenic characterization of an Arkansas isolate of infectious bursal disease virus
US5667785A (en) Vaccine for protection of cats against feline infectious peritonitis
KR100556275B1 (ko) 클라미디아시타시를함유하는고양이백신및그의제조방법
US20020146425A1 (en) Feline vaccines containing chlamydia psittaci and method for making the same
Bayyari The cloning, attenuation, and antigenic characterization of an Arkansas isolate of infectious bursal disease virus
Whetzel Comparison of neutralizing epitopes among classic and variant viruses of infectious bursal disease virus using radioimmunoprecipitation
Vera Expression and immunogenicity of the S1 subunit of the spike glycoprotein of turkey coronavirus in an avian hepatoma cell line

Legal Events

Date Code Title Description
MKLA Lapsed